China plans to approve its first foreign Covid-19 vaccine before July, according to The Wall Street Journal. The move reflects mounting pressure from domestic scientists and foreign business community to…
US health authorities have recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine due to blood clot concerns, according to the Wall Street Journal. The authorities found…
China’s Sinovac Biotech says its third production plant for its COVID-19 vaccine is ready, according to Reuters. The facility has started manufacturing procedures for bulk vaccine ingredient, that doubles annual…
U.S personal incomes plunged $1,516.6 billion or 7.1% in February, according to the Bureau of Economic Analysis press release. The decline reflected the continued impacts of COVID-19 pandemic. Disposable personal…
U.S Data Safety Monitoring Board has expressed concern that AstraZeneca may have included outdated information in trial results of its Covid-19 vaccine, according to CNBC. The concerns cast doubts over…
The US has extended its closure of land borders with Canada and Mexico for non-essential travel until at least April 21, according to Reuters. The travel ban follows an assessment…
Johnson & Johnson’s coronavirus vaccine has been cleared by the European Medicines Agency, according to Bloomberg. The clearance paves the way for the first single-injection shot that will bolster the…
The U.S government can deliver $1400 coronavirus checks once Congress finalizes a new aid bill and President Joe Biden signs it, according to Reuters. Experts warn the expanded child tax…
Moderna Inc. has raised its manufacturing plans for the next two years, according to the company’s press release. The biotechnology company targets to increase capacity to 1.4 billion doses of…
Vaxart’s stock fell 60% after the company failed to find neutralizing antibodies in clinical trials of its oral Covid vaccine, according to CNBC. The disappointing results came even as the…
Eli Lilly recorded a 41.5% growth in fourth-quarter profits ending December 31, according to the company’s press release. The earnings were boosted by higher demand for its diabetes drugs and…
Johnson & Johnson reported revenue of $22.48 billion in the fourth quarter, more than expected $21.67 billion, according to the company’s press release. The company reported earnings per share of…